GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Level Biotechnology Inc (ROCO:3118) » Definitions » PB Ratio

Level Biotechnology (ROCO:3118) PB Ratio : 1.99 (As of May. 08, 2024)


View and export this data going back to 2008. Start your Free Trial

What is Level Biotechnology PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2024-05-08), Level Biotechnology's share price is NT$33.75. Level Biotechnology's Book Value per Share for the quarter that ended in Dec. 2023 was NT$16.93. Hence, Level Biotechnology's PB Ratio of today is 1.99.

The historical rank and industry rank for Level Biotechnology's PB Ratio or its related term are showing as below:

ROCO:3118' s PB Ratio Range Over the Past 10 Years
Min: 1.38   Med: 1.96   Max: 2.89
Current: 2

During the past 13 years, Level Biotechnology's highest PB Ratio was 2.89. The lowest was 1.38. And the median was 1.96.

ROCO:3118's PB Ratio is ranked better than
59.62% of 1310 companies
in the Biotechnology industry
Industry Median: 2.5 vs ROCO:3118: 2.00

During the past 12 months, Level Biotechnology's average Book Value Per Share Growth Rate was 1.30% per year. During the past 3 years, the average Book Value Per Share Growth Rate was 1.20% per year. During the past 5 years, the average Book Value Per Share Growth Rate was 2.00% per year. During the past 10 years, the average Book Value Per Share Growth Rate was 0.90% per year.

During the past 13 years, the highest 3-Year average Book Value Per Share Growth Rate of Level Biotechnology was 3.00% per year. The lowest was -1.70% per year. And the median was 1.20% per year.

Back to Basics: PB Ratio


Level Biotechnology PB Ratio Historical Data

The historical data trend for Level Biotechnology's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Level Biotechnology PB Ratio Chart

Level Biotechnology Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.71 1.84 1.78 1.65 1.80

Level Biotechnology Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.65 1.76 1.88 1.86 1.80

Competitive Comparison of Level Biotechnology's PB Ratio

For the Biotechnology subindustry, Level Biotechnology's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Level Biotechnology's PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Level Biotechnology's PB Ratio distribution charts can be found below:

* The bar in red indicates where Level Biotechnology's PB Ratio falls into.



Level Biotechnology PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Level Biotechnology's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2023)
=33.75/16.931
=1.99

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.


Level Biotechnology  (ROCO:3118) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.


Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.


Level Biotechnology PB Ratio Related Terms

Thank you for viewing the detailed overview of Level Biotechnology's PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Level Biotechnology (ROCO:3118) Business Description

Traded in Other Exchanges
N/A
Address
No.80, Lane 169, Kangning Street, Hsi-Chih, New Taipei, TWN, 221
Level Biotechnology Inc is a Taiwan based company engages in the provision of biotechnological services. It offers cell culture, immune protein, gene nucleic acids, and molecular biology, and instruments and equipment. It offers preclinical trial services in the areas of mammalian toxicology, genetic toxicology, pharmacology, biocompatibility, and model animal production.

Level Biotechnology (ROCO:3118) Headlines

No Headlines